The Manufacturers Life Insurance Company Has $41.05 Million Stake in Revvity Inc. $RVTY

The Manufacturers Life Insurance Company lifted its stake in Revvity Inc. (NYSE:RVTY) by 5.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 368,938 shares of the company’s stock after buying an additional 20,278 shares during the period. The Manufacturers Life Insurance Company’s holdings in Revvity were worth $41,048,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in RVTY. New Mexico Educational Retirement Board increased its stake in Revvity by 1.9% during the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after acquiring an additional 100 shares during the period. Allworth Financial LP lifted its position in shares of Revvity by 8.9% during the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after acquiring an additional 104 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in shares of Revvity by 5.4% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,074 shares of the company’s stock valued at $231,000 after acquiring an additional 106 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of Revvity by 17.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after purchasing an additional 109 shares in the last quarter. Finally, Angeles Wealth Management LLC increased its position in shares of Revvity by 2.0% in the second quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company’s stock worth $646,000 after purchasing an additional 112 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

RVTY has been the subject of a number of analyst reports. Evercore reaffirmed an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Wolfe Research began coverage on shares of Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. TD Cowen restated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Finally, Royal Bank Of Canada started coverage on shares of Revvity in a report on Tuesday, September 1st. They set a “sector perform” rating and a $135.00 price target for the company. Four analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $116.57.

Revvity Trading Up 2.9%

Shares of RVTY opened at $124.46 on Friday. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $133.00. The business’s fifty day moving average is $117.71 and its 200-day moving average is $103.21. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The firm has a market cap of $13.89 billion, a price-to-earnings ratio of 59.27, a PEG ratio of 2.20 and a beta of 1.09.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. During the same quarter in the previous year, the firm earned $1.18 EPS. Revvity’s revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities analysts anticipate that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s payout ratio is currently 13.33%.

About Revvity

Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.

The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.

Revvity was established in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.